FTO

Top Stories Today

Featured

RSS Feed

Sugar Editorial Picks

Your Desire For French Fries Could Be in Your Genes

Dec 11, 2008 - Some people (OK, a lot of people) are drawn to fattening foods. They can't resist brownie sundaes, buttery scones, and french fries. Now it seems a lack of willpower may not be the only culprit: New research shows it could be because of your genes. - 19 Comments

Diabetes - type 2

Oct 08, 2008 - In This Report

Highlights
Introduction
Causes
Risk Factors
Symptoms
Screening Tests
Treatment
Lifestyle Changes
Medications
Long-Term Complications
Emergency Complications
Resources
References

HEALTH GUIDE REFERENCE FROM A.D.A.M Highlights Drug Approvals

Sitagliptin (Januvia), the first in a new class of diabetes drugs called DPP-4 inhibitors, was approved in 2006.
Janumet, a 2-in-1 pill that contains both sitagliptin and metformin, was approved in 2007.
These drugs are taken by mouth and may be more convenient for patients than exenatide (Byetta), a similar drug. DPP-4 inhibitors do not cause weight gain and may pose a lower risk for hypoglycemia than some other diabetes drugs.

Drug Safety Alert Rosiglitazone (Avandia) may significantly increase the risk for heart attack, indicates a review published in the Journal of the American Medical Association. In 2007, a panel of experts from the Food and Drug Administration (FDA) agreed the drug increases the risk of heart attacks -- but concluded it should remain on the market. - 4 Comments